PROACT Xa Trial of Apixaban With On-X Heart Valve Stopped
The DSMB cited a lack of evidence supporting noninferiority of apixaban over warfarin for valve thrombosis and thromboembolism.
Medscape Medical News
source https://www.medscape.com/viewarticle/981644?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/981644?src=rss
Comments
Post a Comment